Guiyang Xintian Pharmaceutical Co Ltd
SZSE:002873
Guiyang Xintian Pharmaceutical Co Ltd
SZSE:002873
Price:
10.61
CNY
0.95%
Market Closed
Market Cap:
¥2.5B
Relative Value
The Relative Value of one
Guiyang Xintian Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 10.61 CNY,
Guiyang Xintian Pharmaceutical Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Guiyang Xintian Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Guiyang Xintian Pharmaceutical Co Ltd Competitors
Guiyang Xintian Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Guiyang Xintian Pharmaceutical Co Ltd
SZSE:002873
|
2.5B CNY | 3.3 | 332.7 | 127.2 | 127.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
973.8B USD | 14.9 | 47.2 | 31.8 | 33.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.5B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.3B CHF | 4.6 | 29.9 | 12.6 | 14.7 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
224.5B GBP | 5.4 | 33.3 | 15.9 | 23.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.1B CHF | 5.4 | 21.6 | 13.3 | 17.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.2B USD | 4.5 | 16 | 10 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.2 | 9.7 | 11.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.5B USD | 2.5 | 20.3 | 7.5 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.8B USD | 2.6 | 17.5 | 6.9 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
